First author (year of publication) | Country | Male n (%) | Age range | Duration (years) | Stroke ascertainment | Cutoff values or quartile (IU/L) | Adjusted covariates |
---|---|---|---|---|---|---|---|
Jousilahti et al. (2000) | Finland | 7176 (48.5) | 25–64 | 13 | T national hospital discharge register (ICD-8 & ICD-9) | M: 10.8, 16.4, 24.6, 64.2 W: 7, 9.9, 13.6, 33.9 | Age, study year, smoking, TC, SBP, DBP, BMI |
Kim et al. (2005) | Korea | 108 464 (100) | 35–59 | 10 | The Korea Medical Insurance Corporation (KMIC) | < 35, (35–69) and ≥ 70 | Age, BMI, blood pressure, FBG, TC, smoking, and alcohol consumption |
Korantzopoulos et al. (2009) | Greece | 175 (53.2) | 77.6 * | 5 | History, physical examination, imaging study (non-contrast brain CT scan), full cardiac evaluation and carotid Doppler ultrasound | < 16, 16–21, 21–27, > 27 | Sex, age, smoking habits, BMI, HTN, DM, metabolic syndrome and serum levels of lipid parameters, glucose, insulin, creatinine, uric acid, AST, ALT, ALP, and total bilirubin |
Shimizu et al. (2010) | Japan | 3471 (36.7) | 40–69 | 18.1 a | Physicians examination, CT/MRI, clinical criteria | M: < 15, (15–24), (24–45), > 45 W: < 8, (9–11), (11–16), > 16 | Age and community, BMI, smoking, alcohol intake, TC, serum triglycerides, serum albumin, AST, ALT, SBP, antihypertensive medication use, and DM |
Weikert et al. (2013) | Germany | 940 (38.9) | 35–65 | 8.2 b | Medical records and death certificates, brain imaging (MRI or CT), and ICD-10 | GGT: M: (3.3–15.4), (16.5–25.3), (26.4–42.9), (44.0-2401) W: (1.1–7.7), (8.8–12.1), (13.2–19.8), (20.9–485) ALT: M: (5.5–17.6), (18.7–24.2), (25.3–35.2), (36.3–265) W: (2.2–12.1), (13.2–15.4), (16.5–20.9), (22.0-209) | Age, sex, BMI, waist circumference, smoking, alcohol intake, education, sports, HTN, DM, total and HDL-cholesterol, and hsCRP |
Shimizu et al. (2013) | Japan | 4098 (38.1) | 40–69 | 16 | National insurance claims, physicians, death certificates, and cardiovascular risk surveys | M: 63, (63–72), (73–83), (84–96),96 W: 59, (59–70), (71–82), (83–98), 98 | Age and community, BMI, smoking, alcohol consumption, TC, serum albumin, AST, ALT, g-GTP, GFR, SBP, antihypertensive medication use, DM, thyroid disease, and for women menopausal status |
Ryu et al. (2014) | South Korea | 558 (51.6%) | 20–82 | 1 | MRI brain, assessment of FLIAR and T1-weighted sequences | <53, (54–63), (64–76), ≥ 77 | Age, sex, HTN, DM, smoking, CHD, serum phosphate, calcium, ALT, LDL-cholesterol, C-reactive protein (log-transformed), and GFR |
Tan et al. (2016) | China | 760 (57.0) | 18–39 | 5.5 | WHO criteria and CT or MRI scan | AST: (5–18), (19–22), (23–29), (30–531) GGT: (7–16), (17–25), (26–42), (43–898) | Age, gender, HTN, DM, dyslipidemia, atrial fibrillation, history of stroke, alcohol consumption and smoking, NIHSS score, and SBP |
Dar et al. (2016) | Pakistan | 288 (73.8) | 40–80 | 0.5 | CT scan of brain was performed, and diagnosis was confirmed | > 27 IU/L | N/A |
Liang et al. (2017) | China | 312 (64.2) | 65.59 * | 2.5 | According to the WHO criteria | N/A | Age, sex, SBP, DBP, cigarette smoking |
Uehara et al. (2018) | Japan | 55 (67) | 69.3 * | 7.5 | DWI to evaluate whether acute ischemic lesions were present | ALP: ≥292 U/L | N/A |
Alexander et al. (2018) | United States of America | 13,607 (45%) | 64.7 * | 4 | Medical records and death certificates | AST: M: (15.4, 18.5, 21.3, 25.5), W: AST (14.1, 16.4, 19.4, 23.1) ALT: M: (12.1, 15.1, 18.9, 24.2), W: (9.3, 12.5, 14.9, 19.2) GGT: M: (17.0 21.6, 28.1, 41.8), W: (12.8, 16.9, 22.6, 31.2) | Age, race, and Framingham stroke risk factors |
Yang et al. (2018) | South Korea | 236,889 (51.9%) | 20–84 | 10 | General health clinical examination and ICD-10, code: I63 | (10–17), (13–25), (18–39), (32–90) | Age, sex, alcohol consumption, BMI, SBP, FBG, TC, hemoglobin, AST, ALT, DM, previous stroke, HTN, atrial fibrillation, ischemic heart disease, heart failure, liver disease, cancer, CKD, osteoporotic fracture, smoking status, antiepileptic drug or rifampicin use, pregnancy within 1 year, and social economic status |
Yang et al. (2020) | South Korea | 525 (59.6) | 68.93 * | 15 | The National Institutes of Health Stroke Scale score, and TOAST classification | M: ≤20, (21–29), (30–53), and ≥ 54 W: ≤14, (15–21), (22–34), and ≥ 35 | Sex, age, BMI, SBP, FBG, TC, AST, ALT, previous stroke, HTN, DM, hyperlipidemia, liver disease, and smoking |
Ruban et al. (2020) | United States of America | 5,504 (43.7) | 45–46 | 24.2 a | Stroke hospitalizations records, ICD-9 or ICD-10 and physician review | AST: M: <12, 12–15, 16–21, ≥ 25; W: <16, 16–18, 19–21, ≥ 22 ALT: M: <18, 18–21, 21–25, ≥ 22; W: <12, 10–12, 13–16, ≥ 17 GGT: M: <18, 18–24, 25–37, ≥ 38; W: <13, 13–17, 18–28, ≥ 29 | Age, sex, race-center; BMI, smoking status, drinking status, education level, SBP, HTN medication, DM, HDL, TC, lipids medication, and CHD |
Lee et al. (2021) | Korea | 118,375 (56.5%) | 57.8 * | 5 | Medical records and ICD, code: I63 | <16, (≥ 16, < 24) (≥ 24, < 41), ≥ 41 | Age, gender, BMI, systolic BP, FBG, TC, eGFR, smoking amount (pack-year), alcohol intake and physical activity |
Li et al. (2022) | China | 8,506 (68.03) | 62.33 * | 4 | WHO criteria, and neuroimaging (MRI or brain CT) | M: <19, 19–27, 27–43, ≥ 43 W: <14, 14–20, 20–29, ≥ 29) | Age and sex, BMI, smoking, alcohol consumption, medical histories, SBP, DBP, NIHSS score at admission, pre-stroke mRS score, TOAST types (including large-artery atherosclerosis, cardioembolic, small-vessel occlusion, other determined etiology, and undetermined cause), medications during hospitalization (including antiplatelet therapy, anticoagulation treatment, antihypertensive treatment, lipid-lowering drugs), and laboratory tests (FBG, TC, triglycerides, ALT, AST levels) |
Kim et al. (2023) | Korea | 1,968 (63.6) | 48–87 | 8.9 a | Hospitalization records with stroke code ICD-10, code: I63 | M: ≤20, 21–30, 31–52, ≥ 54 W: ≤11, 12–15, 16–22, ≥ 23 | Age, sex, residential area, health insurance type, insurance premium, BMI, fasting serum glucose, TC, AST, ALT, cigarette smoking, alcohol consumption, physical activity, family history of stroke, Charlson comorbidity index, and aspirin use, presence of atrial fibrillation/flutter |
Liu et al. (2023) | China | 11,408 (43.2) | M: 65.2 * W:58.9 * | 7.3 c | Hospital records, and medical insurance documents | M: < 69, 69–84, 84–100, > 100 W: < 71, 71–87, 87–105, > 105 | Age, admission batch, BMI, smoking status, drinking status, physical activity, HTN, hyperlipidemia, DM, aspirin usage, anticoagulants usage, menopausal status (women only), family history of CVD, and eGFR, WBC |
Arafa et al. (2023) | Japan | 3,379 (45.7) | < 50, 50–59, 60–69, or ≥ 70 ** | 16.7 a | The US National Survey of Stroke criteria based on CT or MRI images | ALT: ≤ 30, 31–50, > 50 AST: ≤ 30, 31–50, > 50 GGT: ≤ 50, 51–100, > 100 | Age, BMI, smoking, alcohol consumption, HTN, DM, HDL-C, TC, CKD, and cardiac murmur |